Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04251416
Title A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Alessandro Santin
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.